
Canada - TSX Venture Exchange - TSX-V:IOM - Common Stock
The current stock price of IOM.CA is 5.4 null. In the past month the price decreased by -34.94%. In the past year, price increased by 275%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| WELL-DB.CA | WELL HEALTH TECHNOLOGIES | N/A | 25.39B | ||
| DNTL.CA | DENTALCORP HOLDINGS LTD | 20.62 | 2.09B | ||
| WELL.CA | WELL HEALTH TECHNOLOGIES COR | N/A | 977.63M | ||
| AIDX.CA | HEALWELL AI INC | N/A | 258.41M | ||
| NLH.CA | NOVA LEAP HEALTH CORP | 30 | 26.19M | ||
| NPTH.CA | NEUPATH HEALTH INC | N/A | 23.03M | ||
| PHA.CA | PREMIER HEALTH OF AMERICA IN | N/A | 1.11M |
Assure Holdings Corp is a US-based company operating in Health Care Providers & Services industry. The company is headquartered in Denver, Colorado and currently employs 91 full-time employees. The company went IPO on 2008-07-02. Assure Holdings Corp. provides intraoperative neuromonitoring (IONM) surgical support services primarily associated with spine and head surgeries. The firm primarily engages in the neuromonitoring of neurosurgeries, spinal procedures and vascular surgeries. The company applies its neuromonitoring platform to additional surgical verticals such as ear nose and throat, orthopedic and others. The company provides IONM services from scheduling of the intraoperative neurophysiologic (INP) and supervising practitioner, real time monitoring and subsequent billing for the services. The firm provides IONM services for approximately 131 surgeons in 66 hospitals and surgery centers, located in Colorado, Texas, Louisiana, Pennsylvania, Michigan, South Carolina and Arizona. The firm operates through its two indirect subsidiaries: Assure Neuromonitoring, LLC (Neuromonitoring) and Assure Networks, LLC (Networks).
Assure Holdings Corp
4600 S Ulster St Ste 1225
Denver COLORADO 80237 US
CEO: John A. Farlinger
Employees: 91
Phone: 17202873039.0
Assure Holdings Corp is a US-based company operating in Health Care Providers & Services industry. The company is headquartered in Denver, Colorado and currently employs 91 full-time employees. The company went IPO on 2008-07-02. Assure Holdings Corp. provides intraoperative neuromonitoring (IONM) surgical support services primarily associated with spine and head surgeries. The firm primarily engages in the neuromonitoring of neurosurgeries, spinal procedures and vascular surgeries. The company applies its neuromonitoring platform to additional surgical verticals such as ear nose and throat, orthopedic and others. The company provides IONM services from scheduling of the intraoperative neurophysiologic (INP) and supervising practitioner, real time monitoring and subsequent billing for the services. The firm provides IONM services for approximately 131 surgeons in 66 hospitals and surgery centers, located in Colorado, Texas, Louisiana, Pennsylvania, Michigan, South Carolina and Arizona. The firm operates through its two indirect subsidiaries: Assure Neuromonitoring, LLC (Neuromonitoring) and Assure Networks, LLC (Networks).
The current stock price of IOM.CA is 5.4 null. The price decreased by -7.69% in the last trading session.
IOM.CA does not pay a dividend.
IOM.CA has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
IOM.CA stock is listed on the TSX Venture Exchange exchange.
You can find the ownership structure of Assure Holdings Corp (IOM.CA) on the Ownership tab.
ChartMill assigns a technical rating of 3 / 10 to IOM.CA. When comparing the yearly performance of all stocks, IOM.CA is one of the better performing stocks in the market, outperforming 96.79% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to IOM.CA. No worries on liquidiy or solvency for IOM.CA as it has an excellent financial health rating, but there are worries on the profitability.
Over the last trailing twelve months IOM.CA reported a non-GAAP Earnings per Share(EPS) of -4.1. The EPS increased by 87.15% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -10.87% | ||
| ROA | -7.01% | ||
| ROE | N/A | ||
| Debt/Equity | 0.48 |
For the next year, analysts expect an EPS growth of 100.26% and a revenue growth 639.87% for IOM.CA